NCT00219986View on ClinicalTrials.gov

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

September 30, 2005

Conditions
HIV Infections
Interventions
DRUG

Potent HAART during acute or early HIV-1 infection

Trial Locations (1)

10021

Rockefeller University Hospital, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT00219986 - Phase I/II, Open-Label Trial of Three Monoclonal Antibodies | Biotech Hunter | Biotech Hunter